Among the thirty-one patients, five (16.1%) had causative germline variants predisposing them to myeloid neoplasms in the GATA2, PGM3, and ETV6 genes (Table 2), and all of these identified variants have been previously reported [25,26,27,28,29,30]. Here, GATA2 is linked to myeloid neoplasm.